Clinicians will encounter more patients at risk for CHF as the population ages and cardiovascular risk factors become more prevalent.
The researchers found that during 13,509 patient-years of follow-up, 3166 patients had 405 first bleeding events.
Researchers found that 16% of patients received doses inconsistent with US Food and Drug Administration labeling.
The therapy may be cost-effective for patients with a predicted 1-year VTE risk of 17.5% or more.
Blood pressure levels below the recommended targets lower risk of CVD and all-cause mortality.
Compared with individuals reporting chocolate intake less than once per month, the rate of AF was lower for people consuming chocolate regularly.
The ALLHAT-LLT trial showed that statin therapy for primary cardiovascular prevention may not benefit adults older than 65 years of age.
CVD occurred in 11.8% of participants in the vitamin D group and 11.5% in the placebo group.
The USPSTF recommends that pregnant women receive screening for preeclampsia with blood pressure measurements throughout pregnancy.
Apixaban is associated with a lower risk of gastrointestinal bleeding than rivaroxaban or dabigatran.
Nine million fewer adults would be taking statins if clinicians followed the USPSTF guidelines.
Most patients in primary care with undiagnosed chest pain do not undergo diagnostic testing.
The researchers found heterogeneity in the association between recorded alcohol consumption and the initial presentation of 12 cardiovascular diseases.
A 44-year-old man presents to his local urgent care clinic for chest pain radiating up into his neck that is gradually getting worse.
The updated guideline includes recent advances in diagnostic imaging and improvements in catheter-based and surgical interventions for patients with valvular heart disease.
A daily dose of atorvastatin could reduce pulmonary artery pressure among patients with COPD.
In older adults, the consequences of functional impairment include increased morbidity and mortality, and reduced ability to perform activities of daily living.
Anticoagulation with dabigatran was associated with fewer bleeding complications compared with warfarin among patients undergoing ablation for atrial fibrillation.
A longer period between P2Y12 inhibitor administration and primary percutaneous coronary intervention improves coronary reperfusion.
Same-day discharge after percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes was not predictive of 30-day readmission, death, or bleeding.
Researchers find that hospitalizations and deaths among heart failure patients are highest during winter months.
Suboptimal intake of 10 specific dietary factors is associated with a substantial proportion of deaths due to heart disease, stroke, or type 2 diabetes.
NSAID use during ARI was associated with a 3.4-fold increased risk of AMI compared with 2.7-fold increased risk without NSAID use.
Electronic cigarettes cause an imbalance of cardiac autonomic tone and increased oxidative stress, which may increase cardiovascular risk.
Higher-potency statins increased hospitalization for community-acquired pneumonia compared with lower-potency statins.
The AHA found that irregular eating patterns are less ideal for maintaining body weight and cardiometabolic health.
Diabetes without insulin did not appear to increase thromboembolic risk in patients with atrial fibrillation treated with anticoagulation.
RASIs reduced cardiovascular events and death only when compared with placebo but not when compared with active controls.
The device has shut down due to an intermittent connection between the battery and electrical contacts.
An estimated 12.3% of Americans over the age of 21 have masked hypertension.